CHEK2 and neoplasm: In accordance with our suggestion, an increased tumor-infiltrating lymphocytes and longer patient survival were associated with low expression of both ARID1A and ATM/Chk2 axis, and inhibition of ATM selectively potentiated the efficacy of immune checkpoint blockade in ARID1A-depleted tumors but not in WT tumors (115).